Effect of kinesio taping in Parkinson's disease

Effectiveness of kinesio taping in addition to routine physical therapy on balance, gait and quality of life in patients with Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191216045759N1

Enrollment

Registered

2019-12-30

Start date

2019-03-10

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease.

Interventions

Intervention 1: Intervention group: Kinesio taping plus routine physical therapy. Intervention 2: Control group: Routine physical therapy.

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Idiopathic Parkinson’s disease clinically diagnosed by neurologist (according to the UK PDS Brain Bank criteria). Both males and females; 50 - 80 years of age. Modified Hoehn and Yahr stage 2.5 to 3 Movement Disorder Society-Unified Parkinson’s Disease Rating Scale III subscore ‘gait’ or ‘postural stability’ = 1 Receive a stable dopaminergic medication dose (both levo-dopa and/or a dopamine agonist are allowed) for one month before the study

Exclusion criteria

Exclusion criteria: A Mini Mental State Examination score < 24/30 Diagnosed with any other neurological disease other than PD Patient underwent surgery i.e. deep brain stimulation and lesioning surgery (thalamotomy, pallidotomy, subthalamotomy) Fixed vertebral deformities (ankylosing spondylitis, vertebral pathology such as fracture, spinal cord pathology such as syrinx, idiopathic or degenerative scoliosis). Have severe cardiovascular or pulmonary problems Have lower extremity disorders (e.g. deformities, fractures, rheumatologic disease and operations). Visual or acoustic limitations A major change in medicine existed during the training period Any skin or allergic reaction to kinesio tape

Design outcomes

Primary

Measure	Time frame
Balance. Timepoint: Baseline assessment i.e. before intervention (t0), on the day of second session of treatment but before treatment of patient (t1), after end of treatment sessions (t2) and after 3 months of intervention (t3). Method of measurement: Berg balance scale (BBS) and Timed Up and Go Test (TUG). BBS is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4. 0 denotes inability to complete the item, and 4 the ability to accomplish the task independently (total score range, 0–56; higher = better performance). Scores of less than 45 out of 56 are accepted as indicative of balance disorders in the elderly, while scores of less than 43.5 out of 56 are accepted as indicative in Parkinson’s disease. The TUG test is aimed at assessing mobility, balance, walking ability, and fall risk in older adults. The patient is asked to get up from a standard chair, walk at a comfortable and safe speed to a line 3 m away, turn at the line and walk back to the chair to sit down. In patients with Parkinson’s disease, a score higher than 7.95 s may indicate a high risk of falling.;Gait. Timepoint: Baseline assessment i.e. before intervention (t0), on the day of second session of treatment but before treatment of patient (t1), after end of treatment sessions (t2) and after 3 months of intervention (t3). Method of measurement: GAITRite Platinum and Functional gait assessment. Gait function was measured using GAITRite Platinum system (GaitRite, CIR system Inc., USA, 2008). As the subject walked along the walkway, the sensors captured each footfall as a function of time and transferred the gathered information to a personal computer for processing into footfall patterns. The parameters evaluated will be gait velocity, cadence, and step length, and the mean of three repetitions will be used. Functional Gait Assessment: The FGA is a 10-item gait test. Each item is scored on a 4-pointordinal scale with scores of 0, 1, 2, and 3. The maximum total sco	—

Measure

Time frame

Balance. Timepoint: Baseline assessment i.e. before intervention (t0), on the day of second session of treatment but before treatment of patient (t1), after end of treatment sessions (t2) and after 3 months of intervention (t3). Method of measurement: Berg balance scale (BBS) and Timed Up and Go Test (TUG). BBS is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4. 0 denotes inability to complete the item, and 4 the ability to accomplish the task independently (total score range, 0–56; higher = better performance). Scores of less than 45 out of 56 are accepted as indicative of balance disorders in the elderly, while scores of less than 43.5 out of 56 are accepted as indicative in Parkinson’s disease. The TUG test is aimed at assessing mobility, balance, walking ability, and fall risk in older adults. The patient is asked to get up from a standard chair, walk at a comfortable and safe speed to a line 3 m away, turn at the line and walk back to the chair to sit down. In patients with Parkinson’s disease, a score higher than 7.95 s may indicate a high risk of falling.;Gait. Timepoint: Baseline assessment i.e. before intervention (t0), on the day of second session of treatment but before treatment of patient (t1), after end of treatment sessions (t2) and after 3 months of intervention (t3). Method of measurement: GAITRite Platinum and Functional gait assessment. Gait function was measured using GAITRite Platinum system (GaitRite, CIR system Inc., USA, 2008). As the subject walked along the walkway, the sensors captured each footfall as a function of time and transferred the gathered information to a personal computer for processing into footfall patterns. The parameters evaluated will be gait velocity, cadence, and step length, and the mean of three repetitions will be used. Functional Gait Assessment: The FGA is a 10-item gait test. Each item is scored on a 4-pointordinal scale with scores of 0, 1, 2, and 3. The maximum total sco

—

Secondary

Measure	Time frame
Motor Symptoms. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Movement Disorder Society-Unified Parkinson's Disease Rating Scale Motor Examination Part (MDS-UPDRS III).;Freezing of gait. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Freezing of gait questionnaire (FOGQ).;Activities of daily living. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Barthel Index.	—

Measure

Time frame

Motor Symptoms. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Movement Disorder Society-Unified Parkinson's Disease Rating Scale Motor Examination Part (MDS-UPDRS III).;Freezing of gait. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Freezing of gait questionnaire (FOGQ).;Activities of daily living. Timepoint: Baseline assessment i.e. before intervention (t0), after end of treatment sessions (t1) and after 3 months of intervention (t2). Method of measurement: Barthel Index.

—

Countries

Pakistan

Contacts

Public ContactMuhammad Haider Ullah Khan

The University of Lahore

haiderullah@live.com+92 56 3785097

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026